301 related articles for article (PubMed ID: 32896690)
21. The prevalence of heterozygous F12 mutations in Chinese population and its relevance to incidents of thrombosis.
Wu X; Ding Q; Wang X; Dai J; Wu W
BMC Med Genet; 2018 Mar; 19(1):50. PubMed ID: 29587641
[TBL] [Abstract][Full Text] [Related]
22. The Effects of the Contact Activation System on Hemorrhage.
Simão F; Feener EP
Front Med (Lausanne); 2017; 4():121. PubMed ID: 28824910
[TBL] [Abstract][Full Text] [Related]
23. An update on factor XII-driven vascular inflammation.
Mailer RK; Rangaswamy C; Konrath S; Emsley J; Renné T
Biochim Biophys Acta Mol Cell Res; 2022 Jan; 1869(1):119166. PubMed ID: 34699874
[TBL] [Abstract][Full Text] [Related]
24. The contact system in liver injury.
Rangaswamy C; Mailer RK; Englert H; Konrath S; Renné T
Semin Immunopathol; 2021 Aug; 43(4):507-517. PubMed ID: 34125270
[TBL] [Abstract][Full Text] [Related]
25. Factor XII and uPAR upregulate neutrophil functions to influence wound healing.
Stavrou EX; Fang C; Bane KL; Long AT; Naudin C; Kucukal E; Gandhi A; Brett-Morris A; Mumaw MM; Izadmehr S; Merkulova A; Reynolds CC; Alhalabi O; Nayak L; Yu WM; Qu CK; Meyerson HJ; Dubyak GR; Gurkan UA; Nieman MT; Sen Gupta A; Renné T; Schmaier AH
J Clin Invest; 2018 Mar; 128(3):944-959. PubMed ID: 29376892
[TBL] [Abstract][Full Text] [Related]
26. Blood coagulation factor XII--a neglected player in stroke pathophysiology.
Pham M; Stoll G; Nieswandt B; Bendszus M; Kleinschnitz C
J Mol Med (Berl); 2012 Feb; 90(2):119-26. PubMed ID: 21909687
[TBL] [Abstract][Full Text] [Related]
27. Antithrombotic Effect of shRNA Target F12 Mediated by Adeno-Associated Virus.
Li F; Yang X; Liu J; Shu K; Shen C; Chen T; Yang W; Li S; Wang X; Jiang M
Mol Ther Nucleic Acids; 2019 Jun; 16():295-301. PubMed ID: 30959404
[TBL] [Abstract][Full Text] [Related]
28. Factor XII Osaka: abnormal factor XII with partially defective prekallikrein cleavage activity.
Iijima K; Arakawa Y; Sugahara Y; Matsushita M; Moriguchi Y; Shimohiro H; Nakagawa M
Thromb Haemost; 2011 Mar; 105(3):473-8. PubMed ID: 21264442
[TBL] [Abstract][Full Text] [Related]
29. Characterization of congenital factor XII deficiency in Taiwanese patients: identification of one novel and one common mutation.
Chou SC; Lin CY; Lin HY; Pai CH; Yu CY; Kuo SF; Lin JS; Lin PT; Hung MH; Hsieh HN; Liu HC; Shen MC
Int J Hematol; 2022 Oct; 116(4):528-533. PubMed ID: 35675023
[TBL] [Abstract][Full Text] [Related]
30. Are hemostasis and thrombosis two sides of the same coin?
Colman RW
J Exp Med; 2006 Mar; 203(3):493-5. PubMed ID: 16533890
[TBL] [Abstract][Full Text] [Related]
31. Arterial thrombosis is accelerated in mice deficient in histidine-rich glycoprotein.
Vu TT; Zhou J; Leslie BA; Stafford AR; Fredenburgh JC; Ni R; Qiao S; Vaezzadeh N; Jahnen-Dechent W; Monia BP; Gross PL; Weitz JI
Blood; 2015 Apr; 125(17):2712-9. PubMed ID: 25691157
[TBL] [Abstract][Full Text] [Related]
32. Role of platelets, neutrophils, and factor XII in spontaneous venous thrombosis in mice.
Heestermans M; Salloum-Asfar S; Salvatori D; Laghmani el H; Luken BM; Zeerleder SS; Spronk HM; Korporaal SJ; Wagenaar GT; Reitsma PH; van Vlijmen BJ
Blood; 2016 May; 127(21):2630-7. PubMed ID: 26932804
[TBL] [Abstract][Full Text] [Related]
33. Coagulation factor XII in thrombosis and inflammation.
Maas C; Renné T
Blood; 2018 Apr; 131(17):1903-1909. PubMed ID: 29483100
[TBL] [Abstract][Full Text] [Related]
34. Factor XII deficiency: a clinical and molecular genetic study.
Demidova E; Salomashkina V; Pshenichnikova O; Selivanova D; Yakovleva E; Zozulya N; Gorgidze L; Surin V
Int J Hematol; 2023 May; 117(5):678-683. PubMed ID: 36627437
[TBL] [Abstract][Full Text] [Related]
35. Cationic zinc is required for factor XII recruitment and activation by stimulated platelets and for thrombus formation in vivo.
Chaudhry SA; Serrata M; Tomczak L; Higgins S; Ryu J; Laprise D; Enjyoji K; Bekendam R; Kaushik V; Flaumenhaft R; Bendapudi PK
J Thromb Haemost; 2020 Sep; 18(9):2318-2328. PubMed ID: 32542960
[TBL] [Abstract][Full Text] [Related]
36. Factor XII: a novel target for safe prevention of thrombosis and inflammation.
Kenne E; Nickel KF; Long AT; Fuchs TA; Stavrou EX; Stahl FR; Renné T
J Intern Med; 2015 Dec; 278(6):571-85. PubMed ID: 26373901
[TBL] [Abstract][Full Text] [Related]
37. Combined cis-regulator elements as important mechanism affecting FXII plasma levels.
Sabater-Lleal M; Chillón M; Mordillo C; Martínez A; Gil E; Mateo J; Blangero J; Almasy L; Fontcuberta J; Soria JM
Thromb Res; 2010 Feb; 125(2):e55-60. PubMed ID: 19786295
[TBL] [Abstract][Full Text] [Related]
38. Factor XII as a Therapeutic Target in Thromboembolic and Inflammatory Diseases.
Nickel KF; Long AT; Fuchs TA; Butler LM; Renné T
Arterioscler Thromb Vasc Biol; 2017 Jan; 37(1):13-20. PubMed ID: 27834692
[TBL] [Abstract][Full Text] [Related]
39. [Genetic analysis of a Chinese pedigree affected with Congenital coagulation factor XII deficiency due to a c.1A>G start codon variant of F12 gene].
Ji W; Lin S; Chen J; Jin C; Lin X; Ye Z; Qiu L; Qian D
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2023 May; 40(5):547-551. PubMed ID: 37102287
[TBL] [Abstract][Full Text] [Related]
40. Defective glycosylation of coagulation factor XII underlies hereditary angioedema type III.
Björkqvist J; de Maat S; Lewandrowski U; Di Gennaro A; Oschatz C; Schönig K; Nöthen MM; Drouet C; Braley H; Nolte MW; Sickmann A; Panousis C; Maas C; Renné T
J Clin Invest; 2015 Aug; 125(8):3132-46. PubMed ID: 26193639
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
